Ziprasidone-related agranulocytosis following olanzapine-induced neutropenia.
Montgomery
John
J
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines / Q000009:adverse effects; D005260:Female; D006801:Humans; D009503:Neutropenia / Q000139:chemically induced*; D000077152:Olanzapine; D010879:Piperazines / Q000009:adverse effects*; D012559:Schizophrenia / Q000188:drug therapy; D013844:Thiazoles / Q000009:adverse effects*
D014150:Antipsychotic Agents; D010879:Piperazines; D013844:Thiazoles; D001569:Benzodiazepines; C092292:ziprasidone; D000077152:Olanzapine